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Abstract
The possible involvement of phospholipase C (PLC)
in the regulation of insulin secretion is not clearly
understood and neither its isozymes expressed nor
cellular localization in the pancreatic islets is known.
By using specific monoclonal antibodies, we have
investigated the expression and localization of eight
different PLC isozymes, b1, b2, b3, b4, g1, g2, d1, and
d2, in the pancreatic islets of adult mice. Immunohis-
tochemical analysis carried out on paraffin embed-
ded sections showed a distinct pattern of expres-
sion for each of the PLC isozymes. In the central
part of the islets containing b cells, a high level of b4
and moderate levels of b3 and g1 were expressed,
whereas PLC-b1 and -g1 were abundantly expressed
in the exocrine pancreas. These results demonstrat-
ed the heterogeneity in expression of the phospho-
lipase C isozymes in pancreatic islets. It is conceiv-
able that these isozymes are coupled to different
receptors and perform selective tasks in the regula-
tion of insulin secretion for glucose homeostasis.
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Introduction
Glucose is the major stimulant for insulin secretion;
however, the exact mechanism by which glucose ind-
uces insulin secretion still remains to be defined (Vadake-
kalam et al., 1997). Glucose can augment insulin secre-
tion independently of K
+ channel closure, provided that
the cytoplasmic free Ca
2+ concentration is elevated
(Gembal  et al., 1992). A role for phospholipase C (PLC)
in this phenomenon has been both claimed (Turk et al.,
1993; Zawalich and Zawalich, 1997) and refuted
(Gembal  et al., 1993; Vadakekalam et al., 1997). Kelly
et al. (1994) suggested that the enhanced phosphoino-
sitide (PI) response was partially Ca
2+-dependent and
might involve activation of distinct isozymes of PLC ex-
pressed in the islets. Nevertheless, scarce attention has
been paid to determining whether PLC isozymes display
a selective localization in different parts of the pan-
creatic islets. Information on the cellular localization of
PLC proteins in an organ showing a remarkable cellular
heterogeneity is essential for a better understanding of
the specific functions of each isotype. However, current
information about the cellular localization of PLC iso-
zymes has so far been mainly limited to the brain and
related organs (Ross et al., 1989; Peng et al., 1997).
Therefore the pancreatic islet appears to be an inter-
esting region in which to study the distribution of PLC
isozymes mainly to provide clues to solving the contro-
versy concerning the role of PLC isozymes in insulin
secretion (Gembal et al., 1993; Vadakekalam et al.,
1997). Moreover, several protein kinase C (PKC) iso-
zymes, the downstream molecules for the PLC signaling
pathway, were found from mouse pancreatic islets
(Knutson and Hoenig, 1997). In addition, several reports
suggested an active role of G proteins in the insulin
regulation (Sharp, 1996). There is some scattered evi-
dence available to suggest that pancreatic islets express
certain PLCs (Kelly et al., 1995; Zawalich et al., 1995;
Jonas and Henquin, 1996). However, detailed investigation
is necessary to understand their precise localizations.
In the present studies we have investigated the ex-
pression and localization of eight different PLC iso-
zymes, b1, b2, b3, b4, g1, g2, d1, and d2, in the pan-
creatic islets of adult mice using specific monoclonal
antibodies. It was found that pancreatic islets expressed
PLC-g1, -b3, and -b4, by immunohistochemistry. To our
knowledge, this is the first report to examine the com-
plete set of PLC isozymes in pancreatic islets by
immunohistochemistry.
Materials and Methods
Tissue preparation
Pancreas tissues were obtained from 8 week-old micePLCs in pancreatic islets 165
of the wild type C57Bl/6J strain or mutant mice (for PLC-
b1 or -b4) which were anesthetized and perfused trans-
cardially with 4% paraformaldehyde in phosphate-buf-
fered saline (PBS). The tissues were immediately fixed
with 10% neutral buffered formalin, dehydrated in ethanol,
and embedded in paraffin wax. For immunoblotting,
pancreatic islets were obtained by picking from fresh
pancreatic tissues on an inverted microscope. The PLC-
b1 and the PLC-b4 knock out mice have been described
previously (Kim et al., 1997). For hormone studies, both
wild type and knock out mice were sacrificed after 16-h
fasting.
Immunohistochemistry
Serial 5-mm sections were cut from paraffin embedded
tissues. After deparaffinization and hydration, sections
were incubated for 20 min with 10% normal goat serum
to block nonspecific serum protein bindings. Immuno-
histological staining was done as described previously
using monoclonal antibodies diluted 1:200 (Suh et al.,
1988; Lee et al., 1993; Noh et al., 1994). After incuba-
tion for 2 h, sections were washed three times in phos-
phate-buffered saline and incubated with streptavidin-
biotin reagents from the Dako LSAB (labeled streptavidin
biotin) Stain kit (Carpenteria, USA). Dako CSA (catalyzed
signal amplification) kit was also used to amplify the
intensity of staining for PLC-b1, -b2, -b3 and -d2. In
cases of negative control of PLC-g1, -g2 and -d1, parallel
sections were incubated with either PLC-g1, g2 and d1
antibodies absorbed with corresponding peptides or PBS,
substituting primary antibodies (PLC-b2, -b3, and -d2).
PLC-b1 and b4 knock-out mice were used as negative
controls for the PLC-b1 and b4 staining. As positive
controls, the immunohistochemical procedures were re-
peated using the most representative sections of the
various tissues known for expression of each of the
isozymes (Homma et al., 1993; Watanabe et al., 1998)
(PLC-b1: pyramidal cells of cerebrum, PLC-b2: oligod-
endrocytes of brain, PLC-b3: myocardial cells of the
heart, PLC-b4: Purkinje cells of cerebellum, PLC-g1: well-
differentiated colon cancer tissue, and PLC-g2: human B
cell lymphoma tissue, PLC-d1: brain tissue). We did not
perform staining on positive control tissue for -d2. For
staining of several hormones, basically the similar method
was used. All sections were reacted with 3,3-diamino-
benzidine (DAB, Dako), DAB with Nickel (Vector, Burlin-
game, USA), or 3-amino, 3-ethyl carbazole (Dako) as the
chromogen and photographed under the Olympus BH2
light microscope. 
Results 
As shown in Figure 1, mouse pancreatic islets express
certain PLC isozymes, but not all eight isozymes (Figure
1 A-H). The specificity of the immunoreaction was veri-
fied by using knock-out mice or by repeating the experi-
ments with antibodies that had been pretreated with the
corresponding peptide in the cases of PLC-b1, -b4, -g1,
-g2 and -d1 (no peptide was available for monoclonal
antibodies to PLC-b2, -b3, and -d2). After the pretreat-
ment or in knock-out mice, any immunoreactivity was
completely abolished in each case. Moreover we appli-
ed several negative and positive controls, as described
in Materials and Methods, and results on the observed
localization of the various PLC isozymes were in good
agreement with the results available in the literature
(Suh  et al., 1988; Ross et al., 1989; Homma et al., 1993;
Lee  et al., 1993; Noh et al., 1994; Peng et al., 1997;
Watanabe et al., 1998). 
The PLC-b1 immunoreactivity was observed in the
exocrine pancreas but not in the islets of the wild type
mice, whereas this was not observed in the PLC-b1
knock-out mice. We tried to amplify the signal using the
Dako CSA kit, but this isozyme was still not detectable
in pancreatic islet. PLC-b2 showed a negative result in
the islets even with the amplification staining method,
although the same antibody detected this enzyme in
oligodendrocytes of the brain. PLC-b3 was negative in
the islet by the routine staining method, whereas it was
positive in the cardiac muscle cells. But when using the
amplification staining method, this enzyme showed
strong immunoreactivity in the pancreatic islet. Diffuse
and intense expression of PLC-b4 was detected in the
cytoplasm of islet cells even without the signal amplifi-
cation. We used PLC-b4 knock-out mice as a negative
control, and the definite and intense expression of PLC-
b4 obtained in wild type mice was abolished in the
pancreatic islet of the knock-out mice (Figure 2A, B).
The PLC-b4 positive cells were located in the central
part of the pancreatic islet, and were confirmed to be
beta cells since they were also positive for insulin and
negative for glucagon, somatostatin (Figure 3A-D), and
pancreatic polypeptide (data not shown). PLC-g1 was
positive in both exocrine and endocrine pancreas.
These positive reactions were abolished with the prior
incubation of anti PLC-g1 antisera with PLC-g1 peptide
(Figure 2C, D), indicating that the diffuse PLC-g1
staining in the pancreas was specific. The PLC-g2, -d1,
and -d2 were not expressed in the pancreas even with
the amplification method, although these enzymes were
positively stained in B-lymphocytes (g2) or neurons of
the brain (d1). In summary, we detected strong staining
for PLC -b4, and moderate staining for PLC -b3 and -g1
in the pancreatic islet, whereas b1 and g1 predominated
in the exocrine part.
Discussion
Even though the presence of several PLC isozymes
was confirmed in pancreatic islets (Jonas and Henquin,166 Exp. Mol. Med. Vol. 33(3), 164-168, 2001
Figure 2. PLC-b4 and g1 expression in pancreatic islet with negative
controls: the expressions of PLC-b4 and g1 were abolished in negative
controls. A. PLC-b4 in wild type mice (+/+), B. PLC-b4 in knock-out mice
(-/-), C. PLC-g1 with monoclonal antibody, D. PLC-g1 with preadsorption.
Figure 3. PLC-b4 expression in beta cells of pancreatic islet; the beta cells
expressed PLC-b4. A. PLC-b4 immunostain in beta cells of pancreatic islet,
B. Insulin immunostain in beta cells of pancreatic islet, C. Glucagon
immunostain in alpha cells of pancreatic islet, D. Somatostatin immunostain
in delta cells of pancreatic islet.
Figure 1. Immunohistochemistry of PLC isozymes in pancreatic islet: PLC-b3, b4, g1 were expressed in islet, b1 and g1 were in exocrine pancreas. A. PLC-
b1, B. PLC-b2, C. PLC-b3, D. PLC-b4, E. PLC-g1, F. PLC-g2, G. PLC-d1, H. PLC-d2.PLCs in pancreatic islets 167
1996; Zawalich et al., 1995; Kelly et al., 1995), syste-
matic classification has been difficult due to limited
knowledge on their distribution. Zawalich and Zawalich
(1997) demonstrated an augmentation of Ca
2+-induced
inositol phosphate generation in rat islets when diaz-
oxide is present. They further suggested that activation
of the PLC-PKC pathway plays an important role in the
fuel-induced insulin secretion. The present study aimed
at the comprehensive examination on the localization of
eight isozymes of PLC in pancreatic tissues. 
PLC-b1 is known to mediate pertussis toxin-insensi-
tive phosphoinositide hydrolysis (Rhee and Choi, 1992).
Coupling of the enzyme to a cell-surface receptor is
mediated by GTP-binding protein Gq (Rhee and Choi,
1992). In this study, PLC-b1 expression was not found
in pancreatic islets and only at a low level in exocrine
pancreas, as reported previously (Piiper et al., 1997).
No evidence of the PLC-b2 was found in both exocrine
and endocrine pancreas even with the CSA amplifi-
cation method. These findings suggest that PLC-b1 and
-b2 do not participate in the insulin regulation signaling. 
We found a moderate expression of PLC-b3 in pan-
creatic islets using the amplification method, whereas
no expression was found with the routine ABC method,
using the LSAB kit, indicating that pancreatic islets
express PLC-b3 at a relatively lower level than any
other organs such as the heart. Considering that PLC-
b3 is present ubiquitously and PLC-b3 knock-out mice
died at early embryo (Wang et al., 1998), PLC-b3 may
play some role in insulin secretion. Further investigation,
however, is necessary to define its precise functional
role during the insulin secretion process.
Recent reports implicated that PLC-b4 was activated
by the a subunit of the Gq family of G proteins to
mediate phosphoinositide hydrolysis (Ross et al., 1989;
Peng et al., 1997). There are both selectivity and pro-
miscuity in the G protein action inside the b cells (Sharp,
1996). Specifically, Gq and Ga11 protein, which are
known to activate PLC-b4, are located in the islets
(Verspohl and Herrmann, 1996; Shah BH, 1999). Our
results suggest a possibility that PLC-b4 is an important
constituent in the signaling pathway inside the b cells of
the pancreatic islet.
PLC-g1 was also expressed in the central part of the
islets as well as in the exocrine pancreas. PLC-g1 is
known to be involved in the secretory function of the
acinar cells (Wrenn et al., 1996). Its location of expres-
sion suggests the PLC-g1's role in mediating transduc-
tion events underlying trophic signals inside the insulin-
secreting b cells. This idea is consistent with the obser-
vation that the g1 isotype is involved in cellular response
to growth factors.
PLC-g2, -d1 and -d2 were not found in the pancreatic
islet. Gasa et al. (1999) recently reported that PLC-b1,
-b2, -b3, -g1, and -d1 were expressed in insulinoma cell
line and rat islets. Also, the report by Kim et al. (2001)
demonstrated that all four PLC-b isozymes and two
PLC-d were detected in the islets, but PLC-g1 and -g2
were not observed in rat pancreatic islets. The possible
explanations for the discrepancy between the results of
ours and that of others include the differences of
species (mouse vs rat), specimens (tissue vs cell),
methods (immunohistochemistry vs immunoblotting), and
antibodies used.
In conclusion, we believe that our data add valuable
insight into understanding the possible function of PLC
isozymes in the regulation of insulin secretion. However,
it still remains to be elucidated that these molecules in
fact play inhibitory or stimulatory functions in insulin
secretion.
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